: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Influenza

Free Subscription

Articles published in Epidemiol Infect
Retrieve available abstracts of 369 articles:
HTML format

Single Articles

April 2024

PARK JO, Cho HK, Jeon CH, Kim SH, et al
Characteristics and biomarkers associated with mortality in COVID-19 patients presenting to the emergency department.
Epidemiol Infect. 2024;152:e76.
PubMed Abstract available

CHAMBERS T, Anglemyer A, Chen A, Atkinson J, et al
Population and contact tracer uptake of New Zealand's QR-code-based digital contact tracing app for COVID-19.
Epidemiol Infect. 2024;152:e66.
PubMed Abstract available

TSANG TK, Du RQR, Fang VJ, Lau EHY, et al
Decreased risk of non-influenza respiratory infection after influenza B virus infection in children.
Epidemiol Infect. 2024 Apr 8:1-21. doi: 10.1017/S0950268824000542.
PubMed

GUERRERO-SOLER M, Gras-Valenti P, Gomez-Sotero IL, Platas-Abenza G, et al
Impact of COVID-19 on the degree of compliance with hand hygiene: a repeated cross-sectional study.
Epidemiol Infect. 2024;152:e69.
PubMed Abstract available

March 2024

NESTERUK I
Should we ignore SARS-CoV-2 disease?
Epidemiol Infect. 2024;152:e57.
PubMed Abstract available

PENG L, Huang X, Wang C, Xin H, et al
Comparative epidemiology of outbreaks caused by SARS-CoV-2 Delta and Omicron variants in China.
Epidemiol Infect. 2024;152:e43.
PubMed Abstract available

MBOUSSOU F, Nkamedjie P, Oyaole D, Farham B, et al
Rapid assessment of data systems for COVID-19 vaccination in the WHO African Region.
Epidemiol Infect. 2024;152:e50.
PubMed Abstract available

LOZANO D, Dohoo C, Elfstrom D, Carswell K, et al
COVID-19 outbreak at a residential apartment building in Northern Ontario, Canada.
Epidemiol Infect. 2024;152:e53.
PubMed Abstract available

February 2024

YAP WK, Attwell K
Medical exemptions to mandatory vaccinations: The state of play in Australia and a pressure point to watch.
Epidemiol Infect. 2024;152:e40.
PubMed Abstract available

HOEG TB, Haslam A, Prasad V
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds.
Epidemiol Infect. 2024;152:e51.
PubMed Abstract available

WAITE LL, Nahhas A, Irvahn J, Garden G, et al
COVID-19 passenger screening to reduce travel risk and translocation of disease.
Epidemiol Infect. 2024;152:e36.
PubMed Abstract available

GARAY E, Whelan SPJ, DuBois RM, O'Rourke SM, et al
Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico.
Epidemiol Infect. 2024;152:e30.
PubMed Abstract available

January 2024

YAMAYOSHI S, Nagai E, Mitamura K, Hagihara M, et al
Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.
Epidemiol Infect. 2024;152:e24.
PubMed Abstract available

BIRD O, Galiza EP, Baxter DN, Boffito M, et al
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
Epidemiol Infect. 2024;152:e37.
PubMed Abstract available

ROSNER BM, Falkenhorst G, Kumpf I, Enssle M, et al
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).
Epidemiol Infect. 2024;152:e16.
PubMed Abstract available

SARKER P, Haq MA, Akhtar E, Roy AK, et al
Serosurveillance among urban slum and non-slum populations immunized with COVID-19 vaccines in Bangladesh.
Epidemiol Infect. 2024;152:e14.
PubMed Abstract available

LIEPINS T, Davie G, Miller R, Whitehead J, et al
Rural-urban variation in COVID-19 vaccination uptake in Aotearoa New Zealand: Examining the national roll-out.
Epidemiol Infect. 2024;152:e7.
PubMed Abstract available

December 2023

SCHWARTZ RA, Suskind RM
Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.
Epidemiol Infect. 2023;152:e34.
PubMed Abstract available

PARRON I, Carol M, Bes N, Izquierdo C, et al
The impact of COVID-19 pandemic on the incidence of acute gastroenteritis outbreaks in Catalonia (Spain).
Epidemiol Infect. 2023;152:e10.
PubMed Abstract available

November 2023

ALEEM MA, Macintyre CR, Rahman B, Islam AKMM, et al
Association of recent respiratory illness and influenza with acute myocardial infarction among the Bangladeshi population - a case-control study.
Epidemiol Infect. 2023 Nov 30:1-38. doi: 10.1017/S0950268823001863.
PubMed

CHAVES-BLANCO L, de Salazar A, Fuentes A, Vinuela L, et al
Evaluation of a combined detection of SARS-CoV-2 and its variants using real-time allele-specific PCR strategy: an advantage for clinical practice.
Epidemiol Infect. 2023;151:e201.
PubMed Abstract available

GULLE BT, Oren MM, Dal T
COVID-19 vaccine hesitancy in Turkey: A systematic review and meta-analysis.
Epidemiol Infect. 2023;151:e199.
PubMed Abstract available

ELGERSMA IH, Fretheim A, Elstrom P, Aavitsland P, et al
Association between face mask use and risk of SARS-CoV-2 infection: Cross-sectional study.
Epidemiol Infect. 2023;151:e194.
PubMed Abstract available

JIANG H, Gu Z, Liu H, Huang J, et al
Evaluation of phase-adjusted interventions for COVID-19 using an improved SEIR model.
Epidemiol Infect. 2023;152:e9.
PubMed Abstract available

MERINO P, Kupferwasser D, Flores EA, Phan Tran D, et al
Skin and soft tissue infection incidence before and during the COVID-19 pandemic.
Epidemiol Infect. 2023;151:e190.
PubMed Abstract available

October 2023

SEGHEZZO G, Nash SG, Aziz NA, Hope R, et al
Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75, and BQ.1 compared to BA.5 in England.
Epidemiol Infect. 2023;151:e189.
PubMed Abstract available

DAVID JA, Kolipakkam B, Morales MK, Vissichelli NC, et al
Cell-free plasma next-generation sequencing assists in the evaluation of secondary pneumonia in patients with COVID-19: a case series.
Epidemiol Infect. 2023;151:e185.
PubMed Abstract available

RODRIGUEZ-DEL-RIO FJ, Barroso P, Fernandez-de-Mera IG, de la Fuente J, et al
COVID-19 epidemiology and rural healthcare: a survey in a Spanish village.
Epidemiol Infect. 2023;151:e188.
PubMed Abstract available

FLANNAGAN J, Chudasama DY, Hope R, Collin SM, et al
Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks.
Epidemiol Infect. 2023;151:e191.
PubMed Abstract available

KIM JY, Lee WJ, Suh JW, Kim SB, et al
Clinical impact of COVID-19 in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia.
Epidemiol Infect. 2023;151:e180.
PubMed Abstract available

WONG R, Lovier MA
Racial and ethnic disparities in COVID-19 diagnosis and adherence to mitigation behaviours in a national United States older adult sample.
Epidemiol Infect. 2023;151:e175.
PubMed Abstract available

CANELAS-FERNANDEZ J, Mazagatos C, Delgado-Sanz C, Larrauri A, et al
Influenza hospitalizations in Spain between the last influenza and COVID-19 pandemics. 2009-2019.
Epidemiol Infect. 2023 Oct 4:1-32. doi: 10.1017/S0950268823001620.
PubMed

ZHENG L, Qiu L, Wu L, Wang J, et al
Association of SARS-CoV-2 viral load with abnormal laboratory characteristics and clinical outcomes in hospitalised COVID-19 patients.
Epidemiol Infect. 2023;151:e173.
PubMed Abstract available

September 2023

GOPAL RAO G, Jinjika S, James D, Mukombe N, et al
Nosocomial outbreak in a respiratory ward caused by the SARS-CoV-2 Omicron BA 5.2.1 subvariant associated with non-severe illness in vaccinated patients.
Epidemiol Infect. 2023;151:e171.
PubMed Abstract available

TWOHIG KA, Harman K, Zaidi A, Aliabadi S, et al
Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection.
Epidemiol Infect. 2023;151:e169.
PubMed Abstract available

MITANGALA PN, Irenge LM, Musubao ET, Kahindo JBM, et al
Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo.
Epidemiol Infect. 2023;151:e167.
PubMed Abstract available

ZHAO T, Yang Z, Wu Y, Yang J, et al
Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis.
Epidemiol Infect. 2023;151:e176.
PubMed Abstract available

NDZIESSI G, Niama RF, Aloumba AG, Peya JM, et al
Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022.
Epidemiol Infect. 2023;151:e162.
PubMed Abstract available

MELLOR J, Overton CE, Fyles M, Chawner L, et al
Understanding the leading indicators of hospital admissions from COVID-19 across successive waves in the UK.
Epidemiol Infect. 2023;151:e172.
PubMed Abstract available

August 2023

GUHA SK, Sadhukhan S, Niyogi S
COVID-19 cluster identification and support vector machine classifier model construction using global healthcare and socio-economic features.
Epidemiol Infect. 2023;151:e159.
PubMed Abstract available

GOLDSTEIN E
Mortality associated with Omicron and influenza infections in France before and during the COVID-19 pandemic.
Epidemiol Infect. 2023 Aug 25:1-22. doi: 10.1017/S0950268823001358.
PubMed

SZEKELY J, Rakchang W, Rattanaphan P, Kositpantawong N, et al
Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak.
Epidemiol Infect. 2023;151:e146.
PubMed Abstract available

LOVE NK, Douglas A, Gharbia S, Hughes H, et al
Understanding the impact of the COVID-19 pandemic response on GI infection surveillance trends in England, January 2020-April 2022.
Epidemiol Infect. 2023;151:e147.
PubMed Abstract available

JENNINGS S, Corrin T, Waddell L
A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition.
Epidemiol Infect. 2023;151:e145.
PubMed Abstract available

SATALA J, Wozniak A, Fabis M, Gorzelak-Pabis P, et al
Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.
Epidemiol Infect. 2023;151:e140.
PubMed Abstract available

VERONESE G, Mahamid F, Bdier D
Concerns, perceived risk, and hesitancy on COVID-19 vaccine: a qualitative exploration among university students living in the West Bank.
Epidemiol Infect. 2023;151:e139.
PubMed Abstract available

July 2023

WALEKHWA AW, Nakazibwe B, Nantongo M, Wafula ST, et al
COVID-19 second wave and clinical characteristics of cases in Uganda: A retrospective cross-sectional survey of confirmed SARS-CoV-2 cases, March-June 2021.
Epidemiol Infect. 2023;151:e142.
PubMed Abstract available

HALEVI A, Shkalim Zemer V, Embar T, Jacobson E, et al
Attitudes toward COVID-19 vaccination of healthcare workers in Israel and vaccination rates during vaccine rollout.
Epidemiol Infect. 2023;151:e132.
PubMed Abstract available

DE CARVALHO FS, Slack SD, Barbosa-Junior F, de Campos MR, et al
Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the UnCoVER-Brazil project.
Epidemiol Infect. 2023;151:e126.
PubMed Abstract available

FUNK T, Espenhain L, Moller FT, Ethelberg S, et al
Factors associated with the formation of SARS-CoV-2 case-clusters in Danish schools: a nationwide register-based observational study.
Epidemiol Infect. 2023;151:e168.
PubMed Abstract available

GERRITZEN I, Brus IM, Spronk I, Biere-Rafi S, et al
Identification of post-COVID-19 condition phenotypes, and differences in health-related quality of life and healthcare use: a cluster analysis.
Epidemiol Infect. 2023;151:e123.
PubMed Abstract available

BLACKBURN AM, Han H, Gallegos A
Cross-language validation of COVID-19 Compliance Scale in 28 languages.
Epidemiol Infect. 2023;151:e119.
PubMed Abstract available

ROGERS JH, Cox SN, Link AC, Nwanne G, et al
Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study.
Epidemiol Infect. 2023;151:e129.
PubMed Abstract available

HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK - ERRATUM.
Epidemiol Infect. 2023;151:e108.
PubMed

KULIMBET M, Saliev T, Alimbekova G, Ospanova D, et al
Study of seroprevalence of SARS-CoV-2 in Kazakhstan.
Epidemiol Infect. 2023;151:e116.
PubMed Abstract available

RIEKKINEN M, Kajova M, Eriksson M, Luukkainen A, et al
Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults: symptomatic COVID-19 only contracted by those without recent infection.
Epidemiol Infect. 2023;151:e113.
PubMed Abstract available

TOAN DTT, Pham TH, Nguyen KC, Pham QT, et al
Shift from a Zero-COVID strategy to a New-normal strategy for controlling SARS-COV-2 infections in Vietnam.
Epidemiol Infect. 2023;151:e117.
PubMed Abstract available

June 2023

GUO Y, Zeng X, Li L, Wang L, et al
The impact of HBV infection on clinical outcomes of COVID-19 patients: a systematic review and meta-analysis.
Epidemiol Infect. 2023;151:e135.
PubMed Abstract available

LUO Y, Li Y, Xiao S, Lei H, et al
Comparative analysis of inflight transmission of SARS-CoV-2, influenza, and SARS-CoV-1.
Epidemiol Infect. 2023 Jun 23:1-22. doi: 10.1017/S0950268823001012.
PubMed

RAPTI I, Asimakopoulos A, Liontos A, Kosmidou M, et al
Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19 - Corrigendum.
Epidemiol Infect. 2023;151:e91.
PubMed

LEOPARDI S, Desiato R, Mazzucato M, Orusa R, et al
One health surveillance strategy for coronaviruses in Italian wildlife.
Epidemiol Infect. 2023;151:e96.
PubMed Abstract available

HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK.
Epidemiol Infect. 2023;151:e98.
PubMed Abstract available

May 2023

HSU CY, Chen JK, Wikramaratna PS, Yen AM, et al
Can ship travel contain COVID-19 outbreak after re-opening: a Bayesian meta-analysis.
Epidemiol Infect. 2023;151:e99.
PubMed Abstract available

SABIR QUA, Shafqat A, Aslam M
Prediction of the COVID-19 transmission: a case study of Pakistan.
Epidemiol Infect. 2023;151:e89.
PubMed Abstract available

LUO E, Zhong Q, Wen Y, Cai J, et al
Development and external validation of a prognostic tool for nonsevere COVID-19 inpatients.
Epidemiol Infect. 2023;151:e128.
PubMed Abstract available

CHANG H, Zhang X, Su H, Cai J, et al
Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China.
Epidemiol Infect. 2023;151:e81.
PubMed Abstract available

SCHOEPS A, Walter J, Vogt M, Bent S, et al
Direct and indirect vaccination effects on SARS-CoV-2 infection in day-care centres: Evaluating the policy for early vaccination of day-care staff in Germany, 2021.
Epidemiol Infect. 2023;151:e80.
PubMed Abstract available

SHI T, Huang L
Prevalence of respiratory pathogens and risk of developing pneumonia under non-pharmaceutical interventions in Suzhou, China.
Epidemiol Infect. 2023;151:e82.
PubMed Abstract available

April 2023

JOVANOVIC V, Milic M, Dotlic J, Cvjetkovic S, et al
Mandatory and seasonal vaccination against COVID-19: Attitudes of the vaccinated people in Serbia.
Epidemiol Infect. 2023;151:e83.
PubMed Abstract available

FRILLI E, Amodeo D, Cevenini G, Nante N, et al
Effectiveness of near-UVA in SARS-CoV-2 inactivation.
Epidemiol Infect. 2023;151:e76.
PubMed Abstract available

MERCKX J, Callies M, Kabouche I, Desombere I, et al
SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
Epidemiol Infect. 2023;151:e75.
PubMed Abstract available

WHITEHEAD J, Gan H, Heerikhuisen J, Gray G, et al
Inequities in COVID-19 Omicron infections and hospitalisations for Maori and Pacific people in Te Manawa Taki Midland region, New Zealand.
Epidemiol Infect. 2023;151:e74.
PubMed Abstract available

ALHARBI B, Jennison AV, Hicks V, Whiley DM, et al
Decreased Neisseria gonorrhoeae genotypic diversity following COVID-19 restrictions in Queensland, Australia 2020.
Epidemiol Infect. 2023;151:e67.
PubMed Abstract available

PRABHU VG, Hand WR, Isik T, Song Y, et al
Risk-adjusted policies to minimise perioperative staffing shortages during a pandemic: An agent-based simulation study.
Epidemiol Infect. 2023;151:e66.
PubMed Abstract available

AHMED A, DeWitt ME, Dantuluri KL, Castri P, et al
Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina.
Epidemiol Infect. 2023;151:e63.
PubMed Abstract available

March 2023

GOODWIN B, Zia H, Lo DF
Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a critical review.
Epidemiol Infect. 2023;151:e52.
PubMed

ALLEN H, Tessier E, Turner C, Anderson C, et al
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.
Epidemiol Infect. 2023;151:e58.
PubMed Abstract available

MIZOUE T, Yamamoto S, Oshiro Y, Inamura N, et al
Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants.
Epidemiol Infect. 2023;151:e48.
PubMed Abstract available

February 2023

CAPELASTEGUI F, Flannagan J, Augarde E, Tessier E, et al
Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19.
Epidemiol Infect. 2023;151:e51.
PubMed Abstract available

SALAMA M, Amitai Z, Sheffer R
Demographic and clinical characteristics of children and adolescents hospitalised with laboratory-confirmed COVID-19 in the Tel-Aviv District, Israel, 2020-2022.
Epidemiol Infect. 2023;151:e42.
PubMed Abstract available

ZHOU Y, Li Z, Wu W, Xiao J, et al
Transmission trends of the global COVID-19 pandemic with combined effects of adaptive behaviours and vaccination.
Epidemiol Infect. 2023;151:e39.
PubMed Abstract available

HU CY, Lei Y, Tang YW, Cui WS, et al
Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19.
Epidemiol Infect. 2023;151:e34.
PubMed Abstract available

MAIER BF, Rose AH, Burdinski A, Klamser P, et al
Estimating the share of SARS-CoV-2-immunologically naive individuals in Germany up to June 2022.
Epidemiol Infect. 2023;151:e38.
PubMed Abstract available

HALL RN, Jones A, Crean E, Marriott V, et al
Public health interventions successfully mitigated multiple incursions of SARS-CoV-2 Delta variant in the Australian Capital Territory.
Epidemiol Infect. 2023;151:e30.
PubMed Abstract available

TAYLOR MJ, Kumbang J, Bamford K, Mohammed Jazuli Ismail H, et al
A SARS-CoV-2 outbreak associated with five air force bases and a nightclub following the lifting of COVID-19-related social restrictions, United Kingdom, July-to-September 2021.
Epidemiol Infect. 2023;151:e26.
PubMed Abstract available

IRENGE LM, Bulakali HM, Akonkwa AI, Ambroise J, et al
Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo.
Epidemiol Infect. 2023;151:e24.
PubMed Abstract available

NAUTA M, McManus O, Traeholt Franck K, Lindberg Marving E, et al
Early detection of local SARS-CoV-2 outbreaks by wastewater surveillance: a feasibility study.
Epidemiol Infect. 2023;151:e28.
PubMed Abstract available

January 2023

GORI M, Fappani C, Bianchi S, Canuti M, et al
A large A(H3N2) influenza outbreak with a high attack rate in a drug user community in Italy, April 2022.
Epidemiol Infect. 2023 Jan 19:1-13. doi: 10.1017/S0950268823000055.
PubMed

SALMONSMITH J, Ducci A, Balachandran R, Guo L, et al
Use of portable air purifiers to reduce aerosols in hospital settings and cut down the clinical backlog.
Epidemiol Infect. 2023;151:e21.
PubMed Abstract available

ABOU HASSAN FF, Bou Hamdan M, Ali F, Melhem NM, et al
Response to COVID-19 in Lebanon: update, challenges and lessons learned.
Epidemiol Infect. 2023;151:e23.
PubMed Abstract available

MANSOUR GHANAIE R, Jamee M, Khodaei H, Shirvani A, et al
Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a multicentre cross-sectional study on inactivated, mRNA and vector-based vaccines.
Epidemiol Infect. 2023;151:e12.
PubMed Abstract available

GORELIK Y, Dror A, Zayyad H, Wertheim O, et al
Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022.
Epidemiol Infect. 2023;151:e16.
PubMed Abstract available

December 2022

ROY DN, Azam MS, Biswas M, Islam E, et al
Potential factors influencing COVID-19 vaccine acceptance and hesitancy among university students in Bangladesh: a cross-sectional comparative study.
Epidemiol Infect. 2022;151:e11.
PubMed Abstract available

WARD T, Glaser A, Overton CE, Carpenter B, et al
Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
Epidemiol Infect. 2022;151:e32.
PubMed Abstract available

MANICA M, Litvinova M, De Bellis A, Guzzetta G, et al
Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data.
Epidemiol Infect. 2022;151:e5.
PubMed Abstract available

WADE D, Ashton-Butt A, Scott G, Reid SM, et al
High pathogenicity avian influenza: Targeted active surveillance of wild birds to enable early detection of emerging disease threats.
Epidemiol Infect. 2022 Dec 11:1-29. doi: 10.1017/S0950268822001856.
PubMed

HOSKINS S, Beale S, Nguyen V, Boukari Y, et al
Relative contribution of essential and non-essential activities to SARS-CoV-2 transmission following the lifting of public health restrictions in England and Wales.
Epidemiol Infect. 2022;151:e3.
PubMed Abstract available

GASPERINI B, Sarti D, Rondina T, Moretti M, et al
COVID-19 isolation/quarantine rules in home care patients.
Epidemiol Infect. 2022;150:e206.
PubMed Abstract available

November 2022

BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUM.
Epidemiol Infect. 2022;150:e188.
PubMed

PANDEY BD, Ngwe Tun MM, Pandey K, Dumre SP, et al
Has COVID-19 suppressed dengue transmission in Nepal?
Epidemiol Infect. 2022;150:e196.
PubMed Abstract available

BEEBEEJAUN K, Pebody R, Ciobanu S, Pukkila J, et al
UEFA Euro 2020: lessons from the first multi-city international mass gathering during the COVID-19 pandemic.
Epidemiol Infect. 2022;150:e182.
PubMed Abstract available

HEIJMINK L, Tonis J, Gilhuis N, Gerkema M, et al
Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic.
Epidemiol Infect. 2022;150:e193.
PubMed Abstract available

MIYAMA T, Jung SM, Nishiura H
Decrease in overdispersed secondary transmission of COVID-19 over time in Japan.
Epidemiol Infect. 2022;150:e197.
PubMed Abstract available

MCGRATH J, McAloon CG, More SJ, Garrett S, et al
Risk factors for SARS-CoV-2 infection in healthcare workers following an identified nosocomial COVID-19 exposure during waves 1-3 of the pandemic in Ireland.
Epidemiol Infect. 2022;150:e186.
PubMed Abstract available

LEE YH, Choe YJ, Lee H, Choi EH, et al
Spatial distribution of SARS-CoV-2 infection in schools, South Korea.
Epidemiol Infect. 2022;150:e194.
PubMed Abstract available

LE GLASS E, Raoult D, Dubourg G
Snapshot of COVID-19 superinfections in Marseille hospitals: where are the common pathogens?
Epidemiol Infect. 2022;150:e195.
PubMed Abstract available

VALLEE A
Underestimation of the number of COVID-19 cases, an epidemiological threat.
Epidemiol Infect. 2022;150:e191.
PubMed

LIM WW, Cowling BJ, Nakafero G, Feng S, et al
The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom.
Epidemiol Infect. 2022 Nov 4:1-30. doi: 10.1017/S0950268822001753.
PubMed

BLAKEY E, Reeve L, Verlander NQ, Edwards D, et al
Social risk factors for SARS-CoV-2 acquisition in university students: cross sectional survey.
Epidemiol Infect. 2022;150:e201.
PubMed Abstract available

TSUZUKI S, Akiyama T, Matsunaga N, Ohmagari N, et al
Association between physical activity status and severity of COVID-19 in older adults.
Epidemiol Infect. 2022;150:e189.
PubMed Abstract available

EBERHARDT AT, Simoncini M, Pina C, Galoppo G, et al
Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina.
Epidemiol Infect. 2022;150:e187.
PubMed Abstract available

October 2022

GOLDSTEIN E, Fireman BH, Klein NP, Lipsitch M, et al
Prescribing for different antibiotic classes across age groups in the Kaiser Permanente Northern California population in association with influenza incidence, 2010-2018.
Epidemiol Infect. 2022 Oct 26:1-30. doi: 10.1017/S0950268822001662.
PubMed

NOMOTO H, Asai Y, Hayakawa K, Matsunaga N, et al
Impact of the COVID-19 pandemic on racial and ethnic minorities in Japan.
Epidemiol Infect. 2022;150:e202.
PubMed Abstract available

FILIPPATOS F, Tatsi EB, Dellis C, Koukou DM, et al
SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.
Epidemiol Infect. 2022;150:e177.
PubMed Abstract available

MAMISHI S, Olfat M, Pourakbari B, Eshaghi H, et al
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: update and new insights from the second report of an Iranian referral hospital.
Epidemiol Infect. 2022;150:e179.
PubMed Abstract available

WRIGHT E, Pollard G, Robertson H, Anuradha S, et al
Household transmission of the Delta COVID-19 variant in Queensland, Australia: a case series.
Epidemiol Infect. 2022;150:e173.
PubMed Abstract available

September 2022

TAN J, Ge Y, Martinez L, Sun J, et al
Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study.
Epidemiol Infect. 2022;150:e171.
PubMed Abstract available

ZHOU N, Dai H, Zha W, Lv Y, et al
The impact of meteorological factors and PM2.5 on COVID-19 transmission - CORRIGENDUM.
Epidemiol Infect. 2022;150:e164.
PubMed

HAN H, Blackburn AM, Jeftic A, Tran TP, et al
Validity testing of the conspiratorial thinking and anti-expert sentiment scales during the COVID-19 pandemic across 24 languages from a large-scale global dataset.
Epidemiol Infect. 2022;150:e167.
PubMed Abstract available

MAGAZZINO C, Mele M, Coccia M
A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality.
Epidemiol Infect. 2022;150:e168.
PubMed Abstract available

August 2022

CHEN CWS, So MKP, Liu FC
Assessing government policies' impact on the COVID-19 pandemic and elderly deaths in East Asia.
Epidemiol Infect. 2022;150:e161.
PubMed Abstract available

EKROTH AKE, Patrzylas P, Turner C, Hughes GJ, et al
Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.
Epidemiol Infect. 2022;150:e162.
PubMed Abstract available

BAYS D, Bennett E, Finnie T
What effect might border screening have on preventing importation of COVID-19 compared with other infections?: considering the additional effect of post-arrival isolation.
Epidemiol Infect. 2022;150:e159.
PubMed Abstract available

PAGEN DME, Brinkhues S, Dukers-Muijrers NHTM, den Heijer CDJ, et al
Sex and age differences in the proportion of experienced symptoms by SARS-CoV-2 serostatus in a community-based cross-sectional study.
Epidemiol Infect. 2022;150:e157.
PubMed Abstract available

BUCHHOLZ U, An der Heiden M
Serial interval in households infected with SARS-CoV-2 variant B.1.1.529 (Omicron) are even shorter compared to Delta.
Epidemiol Infect. 2022 Aug 5:1-5. doi: 10.1017/S0950268822001248.
PubMed

July 2022

NIELSEN RT, Dalby T, Emborg HD, Larsen AR, et al
COVID-19 preventive measures coincided with a marked decline in other infectious diseases in Denmark, spring 2020.
Epidemiol Infect. 2022;150:e138.
PubMed Abstract available

AL-SHEHARI WA, Yin YA, Wang X, Wang Y, et al
Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018.
Epidemiol Infect. 2022;150:e146.
PubMed Abstract available

SMALLMAN-RAYNOR MR, Cliff AD
Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
Epidemiol Infect. 2022;150:e145.
PubMed Abstract available

PRICE O, Birrell FA, Mifsud EJ, Sullivan SG, et al
Epidemiology of repeat influenza infection in Queensland, Australia, 2005-2017.
Epidemiol Infect. 2022 Jul 18:1-19. doi: 10.1017/S0950268822001157.
PubMed

SILVA MJA, Rodrigues YC, Lima KVB, Lima LNGC, et al
Innate immunity to SARS-CoV-2 infection: a review.
Epidemiol Infect. 2022;150:e142.
PubMed Abstract available

IMPOUMA B, Mboussou F, Farham B, Makubalo L, et al
COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward.
Epidemiol Infect. 2022;150:e143.
PubMed Abstract available

JANNUZZI P, Panza GA
Author response to: Letter to Editor in Response to the association between contact with children and the clinical course of COVID-19.
Epidemiol Infect. 2022;150:e139.
PubMed

LOSS J, Wurm J, Varnaccia G, Schienkiewitz A, et al
Transmission of SARS-CoV-2 among children and staff in German daycare centres.
Epidemiol Infect. 2022;150:e141.
PubMed Abstract available

AUSTHOF E, Bell ML, Riddle MS, Catalfamo C, et al
Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
Epidemiol Infect. 2022 Jul 8:1-22. doi: 10.1017/S0950268822001200.
PubMed

SOYEMI E, Soyemi K
Response to the association between contact with children and the clinical course of COVID-19.
Epidemiol Infect. 2022;150:e140.
PubMed

June 2022

DE MARCO VERISSIMO C, Lopez Corrales J, Dorey AL, Cwiklinski K, et al
Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system.
Epidemiol Infect. 2022;150:e128.
PubMed Abstract available

JUDSON SD, Torimiro J, Pigott DM, Maima A, et al
COVID-19 data reporting systems in Africa reveal insights for future pandemics.
Epidemiol Infect. 2022;150:e119.
PubMed Abstract available

DEN BOOGERT EM, de Lange MMA, Wielders CCH, Rietveld A, et al
Incidence and severity of SARS-CoV-2 infection in former Q fever patients as compared to the Dutch population, 2020-2021.
Epidemiol Infect. 2022;150:e116.
PubMed Abstract available

May 2022

ADAMSON JP, Smith C, Pacchiarini N, Connor TR, et al
A large outbreak of COVID-19 in a UK prison, October 2020 to April 2021.
Epidemiol Infect. 2022;150:e134.
PubMed Abstract available

RAY I, Hasan MM, Shah PA, Sahito AM, et al
HIV epidemic amidst COVID-19 pandemic in India: a conundrum for the country's healthcare system.
Epidemiol Infect. 2022;150:e112.
PubMed Abstract available

XU X, Zhang K, Ma H, Shen X, et al
Differences in service and antibiotics use following symptomatic respiratory tract infections between 2016 and 2021 in rural Anhui, China.
Epidemiol Infect. 2022;150:e117.
PubMed Abstract available

LACY J, Mensah A, Simmons R, Andrews N, et al
Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
Epidemiol Infect. 2022;150:e109.
PubMed Abstract available

PARROTT JC, Annibale AM, Osahan S, Alroy K, et al
Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021.
Epidemiol Infect. 2022;150:e105.
PubMed Abstract available

EDELMAN NL, Simon P, Cassell JA, Kiss IZ, et al
Network analysis of England's single parent household COVID-19 control policy impact: a proof-of-concept study.
Epidemiol Infect. 2022;150:e104.
PubMed Abstract available

LONG H, Li J, Li R, Zhang H, et al
Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19.
Epidemiol Infect. 2022;150:e106.
PubMed Abstract available

SHINGLETON J, Finnie T, Gent N, Bennett E, et al
Assessing the role of imported cases on the establishment of SARS-CoV-2 Delta variant of concern in Bolton, UK.
Epidemiol Infect. 2022;150:e100.
PubMed Abstract available

HIIRONEN I, Saavedra-Campos M, Panitz J, Ma T, et al
Workplace exposures associated with COVID-19: evidence from a case-control study with multiple sampling periods in England, August-October 2020.
Epidemiol Infect. 2022;150:e99.
PubMed Abstract available

THOMAS DR, Fina LH, Adamson JP, Sawyer C, et al
Social, demographic and behavioural determinants of SARS-CoV-2 infection: a case-control study carried out during mass community testing of asymptomatic individuals in South Wales, December 2020.
Epidemiol Infect. 2022;150:e115.
PubMed Abstract available

POKUTNAYA D, Loiacono MM, Booth H, Williams R, et al
The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally-representative retrospective cohort study, 2010-2019.
Epidemiol Infect. 2022 May 6:1-24. doi: 10.1017/S0950268822000838.
PubMed

April 2022

WONG JY, Cheung CM, Bond HS, Cheung JK, et al
Estimating excess septicaemia mortality and hospitalisation burden associated with influenza in Hong Kong, 1998 to 2019.
Epidemiol Infect. 2022;150:e101.
PubMed Abstract available

FABRICIUS G, Borzi RA, Caminos J, Grigera TS, et al
Immunity acquired by a minority active fraction of the population could explain COVID-19 spread in Greater Buenos Aires (June-November 2020).
Epidemiol Infect. 2022;150:e84.
PubMed Abstract available

RICCARDO F, Frisicale EM, Guzzetta G, Ferraro F, et al
Winning during a pandemic: epidemiology of SARS-CoV-2 during EURO2020 in Italy.
Epidemiol Infect. 2022;150:e166.
PubMed Abstract available

March 2022

SCHULMAN A, Bhanot G
Using postal change-of-address data to predict second waves in infections near pandemic epicentres.
Epidemiol Infect. 2022;150:e120.
PubMed Abstract available

BENNEDBAEK M, Button MSF, Nielsen LB, Bybjerg-Grauholm J, et al
Increased transmission of SARS-CoV-2 in Denmark during UEFA European championships.
Epidemiol Infect. 2022;150:e123.
PubMed Abstract available

SARVIKIVI E, Salminen M, Savolainen-Kopra C, Ikonen N, et al
COVID-19 cases in spectators returning to Finland from UEFA Euro 2020 matches in Saint Petersburg.
Epidemiol Infect. 2022;150:e121.
PubMed Abstract available

DASH P, Mansingh A, Nayak SR, Sahoo D, et al
Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India.
Epidemiol Infect. 2022;150:e58.
PubMed Abstract available

HUANG Z, Guo H, Lim HY, Chow A, et al
Determinants of the acceptance and adoption of a digital contact tracing tool during the COVID-19 pandemic in Singapore.
Epidemiol Infect. 2022;150:e54.
PubMed Abstract available

February 2022

GOLDSTEIN E, Fireman BH, Klein NP, Lipsitch M, et al
Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010-2018.
Epidemiol Infect. 2022;150:e85.
PubMed Abstract available

AWAN HA, Sahito AM, Sukaina M, Khatri G, et al
Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems.
Epidemiol Infect. 2022;150:e41.
PubMed Abstract available

PECKEU-ABBOUD L, van Kleef E, Smekens T, Latour K, et al
Factors influencing SARS-CoV-2 infection rate in Belgian nursing home residents during the first wave of COVID-19 pandemic.
Epidemiol Infect. 2022;150:e72.
PubMed Abstract available

YUN KW, Kim YK, Song ES, An HY, et al
Outbreak of COVID-19 among children and young adults in a cancer centre daycare unit.
Epidemiol Infect. 2022;150:e40.
PubMed Abstract available

CORDIOLI M, Mirandola M, Gios L, Gaspari S, et al
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence.
Epidemiol Infect. 2022;150:e48.
PubMed Abstract available

HEINZINGER S, Eberle U, Angermeier H, Flechsler J, et al
Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany) - CORRIGENDUM.
Epidemiol Infect. 2022;150:e24.
PubMed

BROOKES SM, Mansfield KL, Reid SM, Coward V, et al
Incursion of H5N8 High Pathogenicity Avian Influenza Virus (HPAIV) into Gamebirds in England.
Epidemiol Infect. 2022 Feb 10:1-36. doi: 10.1017/S0950268821002740.
PubMed

POMEROY MA, Hoover ER, Dumas BL, Kennedy KS, et al
Decisions to attend holiday gatherings during COVID-19 and engagement in key prevention strategies: United States, January 2021.
Epidemiol Infect. 2022;150:e32.
PubMed Abstract available

SEVINC SA, Metin S, Basi NB, Ling J, et al
Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival.
Epidemiol Infect. 2022;150:e35.
PubMed Abstract available

HAN H
Trust in the scientific research community predicts intent to comply with COVID-19 prevention measures: An analysis of a large-scale international survey dataset.
Epidemiol Infect. 2022;150:e36.
PubMed Abstract available

NA'AMNIH W, Kassem E, Tannous S, Kagan V, et al
Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years.
Epidemiol Infect. 2022;150:e45.
PubMed Abstract available

January 2022

SMITH JAE, Hopkins S, Turner C, Dack K, et al
Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England.
Epidemiol Infect. 2022;150:e42.
PubMed Abstract available

KASSIE A, Handebo S, Adugna A, Shitu K, et al
Violence against girls during COVID-19 pandemic and associated factors in Gondar city, North West Ethiopia.
Epidemiol Infect. 2022;150:e31.
PubMed Abstract available

LIU F, Zhao Z, Ma C, Nie X, et al
Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
Epidemiol Infect. 2022;150:e46.
PubMed Abstract available

ZHOU N, Dai H, Zha W, Lv Y, et al
The impact of meteorological factors and PM2.5 on COVID-19 transmission.
Epidemiol Infect. 2022;150:e38.
PubMed Abstract available

SPAHN C, Hipp AM, Richter B, Nusseck M, et al
Coronavirus vaccination rates in cultural areas in Germany.
Epidemiol Infect. 2022;150:e34.
PubMed Abstract available

DECUIR J, Baggs J, Melgar M, Patel P, et al
Identification and description of patients with multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection using the Premier Healthcare Database.
Epidemiol Infect. 2022;150:e26.
PubMed Abstract available

ESKILD A, Morkrid L, Mortensen SB, Leegaard TM, et al
Prevalence of antibodies against SARS-CoV-2 among pregnant women in Norway during the period December 2019 through December 2020.
Epidemiol Infect. 2022;150:e28.
PubMed Abstract available

LIM C, Nam Y, Oh WS, Ham S, et al
Characteristics of transmission routes of COVID-19 cluster infections in Gangwon Province, Korea.
Epidemiol Infect. 2022;150:e19.
PubMed Abstract available

BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection.
Epidemiol Infect. 2022;150:e20.
PubMed Abstract available

CAVANY S, Bivins A, Wu Z, North D, et al
Inferring SARS-CoV-2 RNA shedding into wastewater relative to the time of infection.
Epidemiol Infect. 2022;150:e21.
PubMed Abstract available

December 2021

NOAH N, Edelstein M
African COVID-19 special issue introduction.
Epidemiol Infect. 2021;149:e257.
PubMed

SCHOOLING CM, Li M, Au Yeung SL
Interleukin-18 and COVID-19.
Epidemiol Infect. 2021;150:e14.
PubMed Abstract available

TSUZUKI S, Ohmagari N, Beutels P
The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan.
Epidemiol Infect. 2021;150:e5.
PubMed Abstract available

MUGHINI-GRAS L, Chaname Pinedo L, Pijnacker R, van den Beld M, et al
Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands.
Epidemiol Infect. 2021;149:e254.
PubMed Abstract available

November 2021

ALJOHANI NI, Mutai K
Effect of non-pharmacological interventions on the COVID-19 epidemic in Saudi Arabia.
Epidemiol Infect. 2021;149:e252.
PubMed Abstract available

MUNCH PK, Espenhain L, Hansen CH, Muller L, et al
Societal activities associated with SARS-CoV-2 infection: a case-control study in Denmark, November 2020.
Epidemiol Infect. 2021;150:e9.
PubMed Abstract available

MAGAZZINO C, Mele M, Schneider N
Assessing a fossil fuels externality with a new neural networks and image optimisation algorithm: the case of atmospheric pollutants as confounders to COVID-19 lethality.
Epidemiol Infect. 2021;150:e1.
PubMed Abstract available

LAI J, Hughes HE, Morbey R, Loveridge P, et al
Developing a sentinel syndromic surveillance system using school-absenteeism data, example monitoring absences over the 2020 COVID-19 pandemic.
Epidemiol Infect. 2021;149:e248.
PubMed Abstract available

TATSI EB, Filippatos F, Michos A
SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.
Epidemiol Infect. 2021;149:e237.
PubMed Abstract available

BAYS D, Bennett E, Finnie T
What effect might border screening have on preventing the importation of COVID-19 compared with other infections? A modelling study.
Epidemiol Infect. 2021;149:e238.
PubMed Abstract available

IMPOUMA B, Mboussou F, Shahpar C, Wolfe CM, et al
Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region 10 months into the pandemic.
Epidemiol Infect. 2021;149:e264.
PubMed Abstract available

IMPOUMA B, Mboussou F, Farham B, Wolfe CM, et al
The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021).
Epidemiol Infect. 2021;149:e263.
PubMed Abstract available

LI R, Li Q, Liu Y, Shen M, et al
Modelling the impact of universal influenza vaccines on seasonal influenza with different subtypes.
Epidemiol Infect. 2021;149:e253.
PubMed Abstract available

October 2021

NICHOLS M, Gollarza L, Palacios A, Stapleton GS, et al
Salmonella illness outbreaks linked to backyard poultry purchasing during the COVID-19 pandemic: United States, 2020.
Epidemiol Infect. 2021;149:e234.
PubMed Abstract available

JUUTINEN A, Sarvikivi E, Laukkanen-Nevala P, Helve O, et al
Closing lower secondary schools had no impact on COVID-19 incidence in 13-15-year-olds in Finland.
Epidemiol Infect. 2021;149:e233.
PubMed Abstract available

HEINZINGER S, Eberle U, Angermeier H, Flechsler J, et al
Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany).
Epidemiol Infect. 2021;149:e226.
PubMed Abstract available

MANCILLA-GALINDO J, Kammar-Garcia A, Martinez-Esteban A, Meza-Comparan HD, et al
COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms.
Epidemiol Infect. 2021;149:e230.
PubMed Abstract available

GONZALEZ F, Vielot NA, Sciaudone M, Toval-Ruiz C, et al
Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in Leon, Nicaragua.
Epidemiol Infect. 2021;149:e247.
PubMed Abstract available

AEMRO A, Amare NS, Shetie B, Chekol B, et al
Determinants of COVID-19 vaccine hesitancy among health care workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study.
Epidemiol Infect. 2021;149:e225.
PubMed Abstract available

SINGH C, Naik BN, Pandey S, Biswas B, et al
Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.
Epidemiol Infect. 2021;149:e224.
PubMed Abstract available

ZHAO X, Shen Z, Sun L, Cheng L, et al
A network meta-analysis of secondary attack rates of COVID-19 in different contact environments.
Epidemiol Infect. 2021;149:e219.
PubMed Abstract available

September 2021

KEITA MB, Pierre F, Ndjomou J, Traore B, et al
The first epidemiological and virological influenza surveillance in the Republic of Guinea revealed the predominance of influenza A/H3N2 and B Victoria viruses.
Epidemiol Infect. 2021 Sep 28:1-20. doi: 10.1017/S0950268821001965.
PubMed

SCHOEPS A, Hoffmann D, Tamm C, Vollmer B, et al
Surveillance of SARS-CoV-2 transmission in educational institutions, August to December 2020, Germany.
Epidemiol Infect. 2021;149:e213.
PubMed Abstract available

CHENG X, Li Y, Zhang Y, Lu J, et al
The characteristics of and responses to the two COVID-19 outbreak waves in Hebei Province of China, January 2020 to February 2021.
Epidemiol Infect. 2021;149:e212.
PubMed Abstract available

AKTAS YILDIRIM S, Sarikaya ZT, Ulugol H, Ozata S, et al
Are surgical and non-operating room intervention safe in the COVID-19 pandemic? A retrospective study.
Epidemiol Infect. 2021;149:e210.
PubMed Abstract available

GOLDENFELD M, Zuckerman N, Amit S, Tal I, et al
First reported nosocomial SARS-CoV-2 outbreak in a hospital-based laundry facility.
Epidemiol Infect. 2021;150:e18.
PubMed Abstract available

MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
Epidemiol Infect. 2021;149:e203.
PubMed

SPINICCI M, Pengue L, Bartolozzi D, Quercioli M, et al
Soccer in the time of COVID-19: 1 year report from an Italian top league club, March 2020-February 2021.
Epidemiol Infect. 2021;149:e207.
PubMed Abstract available

IMPOUMA B, Williams GS, Moussana F, Mboussou F, et al
The first 8 months of COVID-19 pandemic in three West African countries: leveraging lessons learned from responses to the 2014-2016 Ebola virus disease outbreak.
Epidemiol Infect. 2021;149:e258.
PubMed Abstract available

August 2021

ABU JABAL K, Ben-Amram H, Beiruti K, Brimat I, et al
SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
Epidemiol Infect. 2021;149:e239.
PubMed Abstract available

MBOUSSOU F, Impouma B, Farham B, Wolfe CM, et al
Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020.
Epidemiol Infect. 2021;149:e256.
PubMed Abstract available

ALPCAN A, Tursun S, Kandur Y
Vitamin D levels in children with COVID-19: a report from Turkey.
Epidemiol Infect. 2021;149:e180.
PubMed Abstract available

NAESENS R, Mertes H, Clukers J, Herzog S, et al
SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.
Epidemiol Infect. 2021;149:e172.
PubMed Abstract available

BAUMEISTER A, Corrin T, Abid H, Young KM, et al
The quality of systematic reviews and other synthesis in the time of COVID-19.
Epidemiol Infect. 2021;149:e182.
PubMed Abstract available

CHENG CH, Chow CL, Chow WK
A discussion on the minimum required number of tests in two common pooling test methods for SARS-CoV-2.
Epidemiol Infect. 2021;149:e179.
PubMed Abstract available

MELOTTI R, Scaggiante F, Falciani M, Weichenberger CX, et al
Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley.
Epidemiol Infect. 2021;149:e194.
PubMed Abstract available

KELLY G, Petti S, Noah N
Covid-19, non-Covid-19 and excess mortality rates not comparable across countries.
Epidemiol Infect. 2021;149:e176.
PubMed Abstract available

ALVES JD, Abade AS, Peres WP, Borges JE, et al
Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study.
Epidemiol Infect. 2021;149:e185.
PubMed Abstract available

July 2021

OTTAVIANO E, Parodi C, Borghi E, Massa V, et al
Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021.
Epidemiol Infect. 2021;149:e171.
PubMed Abstract available

YI B, Poetsch AR, Stadtmuller M, Rost F, et al
Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
Epidemiol Infect. 2021;149:e177.
PubMed Abstract available

CARLTON LH, Chen T, Whitcombe AL, McGregor R, et al
Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
Epidemiol Infect. 2021;149:e173.
PubMed Abstract available

YAMADA G, Hayakawa K, Matsunaga N, Terada M, et al
Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation.
Epidemiol Infect. 2021;149:e175.
PubMed Abstract available

BREWER TF, Zhang M, Gordon D, Chung RY, et al
Housing, sanitation and living conditions affecting SARS-CoV-2 prevention interventions in 54 African countries.
Epidemiol Infect. 2021;149:e183.
PubMed Abstract available

YAKOB L
Isolation thresholds for curbing SARS-CoV-2 resurgence.
Epidemiol Infect. 2021;149:e168.
PubMed Abstract available

THOMAS BS, Marks NA
Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.
Epidemiol Infect. 2021;149:e197.
PubMed Abstract available

BOENDER TS, Bender JK, Kruger A, Michaelis K, et al
Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice: a cohort study of patient contacts; Germany, 2020.
Epidemiol Infect. 2021;149:e161.
PubMed Abstract available

AKHMETZHANOV AR
Estimation of delay-adjusted all-cause excess mortality in the USA: March-December 2020.
Epidemiol Infect. 2021;149:e156.
PubMed Abstract available

DITE GS, Murphy NM, Allman R
Development and validation of a clinical and genetic model for predicting risk of severe COVID-19.
Epidemiol Infect. 2021;149:e162.
PubMed Abstract available

CARDENAS VM
RE: George et al. 'High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?'
Epidemiol Infect. 2021;149:e151.
PubMed

GEORGE CE, Inbaraj LR
Re: George et al. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
Epidemiol Infect. 2021;149:e152.
PubMed

GOZLAN Y, Reingold S, Koren R, Halpern O, et al
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
Epidemiol Infect. 2021;149:e153.
PubMed Abstract available

WOUDENBERG T, Eberle U, Marosevic D, Liebl B, et al
Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.
Epidemiol Infect. 2021;149:e150.
PubMed Abstract available

ZHANG R, Gao Y, Xie D, Lian R, et al
Characteristics of systematic reviews evaluating treatments for COVID-19 registered in PROSPERO.
Epidemiol Infect. 2021;149:e146.
PubMed Abstract available

MALDONADO MD, Romero-Aibar J, Perez-San-Gregorio MA
COVID-19 pandemic as a risk factor for the reactivation of herpes viruses.
Epidemiol Infect. 2021;149:e145.
PubMed Abstract available

DE MARCO VERISSIMO C, O'Brien C, Lopez Corrales J, Dorey A, et al
Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
Epidemiol Infect. 2021;149:e140.
PubMed Abstract available

GUVEN BB, Erturk T, Kompe O, Ersoy A, et al
Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
Epidemiol Infect. 2021;149:e137.
PubMed Abstract available

May 2021

IMPOUMA B, Mlanda T, Bukhari A, Sie Williams G, et al
Information management practices in the WHO African Region to support response to the COVID-19 pandemic.
Epidemiol Infect. 2021;149:e260.
PubMed Abstract available

JAIN J, Saurabh S, Kumar P, Verma MK, et al
COVID-19 vaccine hesitancy among medical students in India.
Epidemiol Infect. 2021;149:e132.
PubMed Abstract available

MCDONALD SA, van den Wijngaard CC, Wielders CCH, Friesema IHM, et al
Risk factors associated with the incidence of self-reported COVID-19-like illness: data from a web-based syndromic surveillance system in the Netherlands.
Epidemiol Infect. 2021;149:e129.
PubMed Abstract available

DE SOUZA ARAUJO AA, Quintans-Junior LJ, Heimfarth L, Schimieguel DM, et al
Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
Epidemiol Infect. 2021;149:e130.
PubMed Abstract available

HAMMER CC, Cristea V, Dub T, Sivela J, et al
High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.
Epidemiol Infect. 2021;149:e123.
PubMed Abstract available

IMPOUMA B, Mboussou F, Wolfe CM, Farham B, et al
COVID-19 in the WHO African region: using risk assessment to inform decisions on public health and social measures.
Epidemiol Infect. 2021;149:e259.
PubMed Abstract available

April 2021

MAJUMDAR P, Niyogi S
SARS-CoV-2 mutations: the biological trackway towards viral fitness.
Epidemiol Infect. 2021;149:e110.
PubMed Abstract available

CRUZ EHM, Maciel JM, Clozato CL, Serpa MS, et al
Simulation-based evaluation of school reopening strategies during COVID-19: A case study of Sao Paulo, Brazil.
Epidemiol Infect. 2021;149:e118.
PubMed Abstract available

ZHAO S, Yang Z, Musa SS, Ran J, et al
Attach importance of the bootstrap t test against Student's t test in clinical epidemiology: a demonstrative comparison using COVID-19 as an example.
Epidemiol Infect. 2021;149:e107.
PubMed Abstract available

VERA-ZERTUCHE JM, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, et al
Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
Epidemiol Infect. 2021;149:e109.
PubMed Abstract available

MOUSSA R, Majdalani S
Use of the Hayami diffusive wave equation to model the relationship infected-recoveries-deaths of Covid-19 pandemic.
Epidemiol Infect. 2021;149:e138.
PubMed Abstract available

SHARIF N, Ahmed SN, Opu RR, Daullah MU, et al
Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan.
Epidemiol Infect. 2021;149:e103.
PubMed Abstract available

KIM SH, Kim YJ, Jeong YJ, Park JH, et al
Construction of a non-contact community treatment centre for asymptomatic and mildly symptomatic COVID-19 patients during the COVID-19 pandemic.
Epidemiol Infect. 2021;149:e111.
PubMed Abstract available

LOPEZ-CHEDA A, Jacome MA, Cao R, De Salazar PM, et al
Estimating lengths-of-stay of hospitalised COVID-19 patients using a non-parametric model: a case study in Galicia (Spain).
Epidemiol Infect. 2021;149:e102.
PubMed Abstract available

KSHATRI JS, Bhattacharya D, Praharaj I, Mansingh A, et al
Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.
Epidemiol Infect. 2021;149:e139.
PubMed Abstract available

ALLEN N, Riain UN, Conlon N, Ferenczi A, et al
Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Epidemiol Infect. 2021;149:e157.
PubMed Abstract available

DRESSLER A, Finci I, Wagner-Wiening C, Eichner M, et al
Epidemiological analysis of 3,219 COVID-19 outbreaks in the state of Baden-Wuerttemberg, Germany.
Epidemiol Infect. 2021;149:e101.
PubMed Abstract available

BAGGIO JAO, Machado MF, Carmo RFD, Armstrong ADC, et al
COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality - a retrospective study with data from 59 695 individuals.
Epidemiol Infect. 2021;149:e100.
PubMed Abstract available

LUO S, Xin M, Wang S, Zhao J, et al
Behavioural intention of receiving COVID-19 vaccination, social media exposures and peer discussions in China.
Epidemiol Infect. 2021;149:e158.
PubMed Abstract available

ZARE F, Teimouri M, Khosravi A, Rohani-Rasaf M, et al
COVID-19 re-infection in Shahroud, Iran: a follow-up study.
Epidemiol Infect. 2021;149:e159.
PubMed Abstract available

MARCO A, Gallego C, Perez-Caceres V, Guerrero RA, et al
Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison.
Epidemiol Infect. 2021;149:e91.
PubMed Abstract available

KARIMZADEH S, Bhopal R, Nguyen Tien H
Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
Epidemiol Infect. 2021;149:e96.
PubMed Abstract available

IMPOUMA B, Wolfe CM, Mboussou F, Farham B, et al
Monitoring and evaluation of COVID-19 response in the WHO African region: challenges and lessons learned.
Epidemiol Infect. 2021;149:e98.
PubMed Abstract available

HU HY, Yan F, Zhu JM, Karuno AP, et al
Intercontinental transmission and local demographic expansion of SARS-CoV-2.
Epidemiol Infect. 2021;149:e94.
PubMed Abstract available

MOETI M
Leadership, collaboration and using data science to fight COVID-19 in the WHO African region.
Epidemiol Infect. 2021;149:e262.
PubMed

SEMENZA JC, Adlhoch C, Baka A, Broberg E, et al
COVID-19 research priorities for non-pharmaceutical public health and social measures.
Epidemiol Infect. 2021;149:e87.
PubMed Abstract available

MASSAD E, Amaku M, Tadeu Covas D, Fernandes Lopez L, et al
Estimating the effects of reopening of schools on the course of the epidemic of COVID-19.
Epidemiol Infect. 2021;149:e86.
PubMed Abstract available

MAO Y, Tan YR, Thein TL, Chai YAL, et al
Identifying COVID-19 cases in outpatient settings.
Epidemiol Infect. 2021;149:e92.
PubMed Abstract available

March 2021

WANG K, Wang X, Du J, Liu C, et al
Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease.
Epidemiol Infect. 2021;149:e81.
PubMed Abstract available

MUKHERJEE A, Anand T, Agarwal A, Singh H, et al
SARS-CoV-2 re-infection: development of an epidemiological definition from India.
Epidemiol Infect. 2021;149:e82.
PubMed Abstract available

BLANCO N, Stafford KA, Lavoie MC, Brandenburg A, et al
A simple model for the total number of SARS-CoV-2 infections on a national level.
Epidemiol Infect. 2021;149:e80.
PubMed Abstract available

GALLO O, Peris A, Trotta M, Orlando P, et al
Epidemiological analysis of a COVID-19 outbreak associated with an infected surgeon.
Epidemiol Infect. 2021;149:e77.
PubMed Abstract available

OGIMI C, Qu P, Boeckh M, Bender Ignacio RA, et al
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.
Epidemiol Infect. 2021;149:e75.
PubMed Abstract available

KUCHENHOFF H, Gunther F, Hohle M, Bender A, et al
Analysis of the early COVID-19 epidemic curve in Germany by regression models with change points.
Epidemiol Infect. 2021;149:e68.
PubMed Abstract available

KOZER E, Rinott E, Kozer G, Bar-Haim A, et al
Presence of SARS-CoV-2 RNA on playground surfaces and water fountains.
Epidemiol Infect. 2021;149:e67.
PubMed Abstract available

ELSON R, Davies TM, Lake IR, Vivancos R, et al
The spatio-temporal distribution of COVID-19 infection in England between January and June 2020.
Epidemiol Infect. 2021;149:e73.
PubMed Abstract available

TAKEFUJI Y
Fourier analysis using the number of COVID-19 daily deaths in the US.
Epidemiol Infect. 2021;149:e64.
PubMed Abstract available

BOHM S, Woudenberg T, Chen D, Marosevic DV, et al
Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.
Epidemiol Infect. 2021;149:e65.
PubMed Abstract available

February 2021

CASTRO RR, Santos RSC, Sousa GJB, Pinheiro YT, et al
Spatial dynamics of the COVID-19 pandemic in Brazil.
Epidemiol Infect. 2021;149:e60.
PubMed Abstract available

MICHOS A, Savvidou P, Syridou G, Eleftheriou E, et al
SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study.
Epidemiol Infect. 2021;149:e70.
PubMed Abstract available

CHENG A, Chen Y, Gao Y, Sun P, et al
Mobile isolation wards in a fever clinic: a novel operation model during the COVID-19 pandemic.
Epidemiol Infect. 2021;149:e61.
PubMed Abstract available

HONG K, Yum SJ, Kim JH, Chun BC, et al
Re-estimation of basic reproduction number of COVID-19 based on the epidemic curve by symptom onset date.
Epidemiol Infect. 2021;149:e53.
PubMed Abstract available

DUQUE MP, Lucaccioni H, Costa C, Marques R, et al
COVID-19 symptoms: a case-control study, Portugal, March-April 2020.
Epidemiol Infect. 2021;149:e54.
PubMed Abstract available

LEHMANN J, Giesinger JM, Rumpold G, Borena W, et al
Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria.
Epidemiol Infect. 2021;149:e52.
PubMed Abstract available

ZHAO K, Ai L, Zhao Y, Wang T, et al
Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019.
Epidemiol Infect. 2021;149:e62.
PubMed Abstract available

LELIS DA SILVA F, Dias Pita J, Gomes MDA, Lelis da Silva AP, et al
Intraregional propagation of Covid-19 cases in Para, Brazil: assessment of isolation regime to lockdown.
Epidemiol Infect. 2021;149:e72.
PubMed Abstract available

GAO Y, Chen Y, Liu M, Niu M, et al
Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
Epidemiol Infect. 2021;149:e66.
PubMed Abstract available

MIYAMA T, Iritani N, Nishio T, Ukai T, et al
Seasonal shift in epidemics of respiratory syncytial virus infection in Japan.
Epidemiol Infect. 2021;149:e55.
PubMed Abstract available

AI J, Shi N, Shi Y, Xu K, et al
Epidemiologic characteristics and influencing factors of cluster infection of COVID-19 in Jiangsu Province.
Epidemiol Infect. 2021;149:e48.
PubMed Abstract available

SHANG C, Yang Y, Chen GY, Shang XD, et al
A simple transmission dynamics model for predicting the evolution of COVID-19 under control measures in China.
Epidemiol Infect. 2021;149:e43.
PubMed Abstract available

BAILIE CR, Franklin L, Nicholson S, Mordant F, et al
Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort.
Epidemiol Infect. 2021;149:e44.
PubMed Abstract available

WEIBELZAHL S, Reiter J, Duden G
Depression and anxiety in healthcare professionals during the COVID-19 pandemic.
Epidemiol Infect. 2021;149:e46.
PubMed Abstract available

GEORGE CE, Inbaraj LR, Chandrasingh S, de Witte LP, et al
High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
Epidemiol Infect. 2021;149:e39.
PubMed Abstract available

KAMAR A, Maalouf N, Hitti E, El Eid G, et al
Challenge of forecasting demand of medical resources and supplies during a pandemic: A comparative evaluation of three surge calculators for COVID-19.
Epidemiol Infect. 2021;149:e51.
PubMed Abstract available

SINGH RKS, Malik MZ, Singh RKB
Diversity of SARS-CoV-2 isolates driven by pressure and health index.
Epidemiol Infect. 2021;149:e38.
PubMed Abstract available

January 2021

PETT J, McAleavey P, McGurnaghan P, Spiers R, et al
Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020.
Epidemiol Infect. 2021;149:e36.
PubMed Abstract available

PRANATA R, Lim MA, Yonas E, Huang I, et al
Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis.
Epidemiol Infect. 2021;149:e40.
PubMed Abstract available

ZAVASCKI AP
Urgent need for evaluation of point-of-care tests as an RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
Epidemiol Infect. 2021;149:e35.
PubMed

CHOW WK, Chow CL
Response to Letter to Editor by Zavascki A.P.: Urgent need for evaluating point-of-care tests as a RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
Epidemiol Infect. 2021;149:e33.
PubMed

WANG Y, Luo H, Liu S, Hao T, et al
Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.
Epidemiol Infect. 2021;149:e31.
PubMed Abstract available

SETHI SM, Ahmed AS, Hanif S, Aqeel M, et al
Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan.
Epidemiol Infect. 2021;149:e37.
PubMed Abstract available

VENTURELLI S, Benatti SV, Casati M, Binda F, et al
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.
Epidemiol Infect. 2021;149:e32.
PubMed Abstract available

WENG CH, Saal A, McGuire DC, Chan PA, et al
Persistently high SARS-CoV-2 positivity rate and incidence for Hispanic/Latinos during state reopening in an urban setting: a retrospective cohort study.
Epidemiol Infect. 2021;149:e25.
PubMed Abstract available

LE TD, Bosworth M, Ledlow G, Le TT, et al
Influences of reopening businesses and social venues: COVID-19 incidence rate in East Texas county.
Epidemiol Infect. 2021;149:e28.
PubMed Abstract available

WEI J, Guo S, Long E, Zhang L, et al
Why does the spread of COVID-19 vary greatly in different countries? Revealing the efficacy of face masks in epidemic prevention.
Epidemiol Infect. 2021;149:e24.
PubMed Abstract available

ISHIKAWA G, Argenti G, Fadel CB
Non-specific blood tests as proxies for COVID-19 hospitalisation: are there plausible associations after excluding noisy predictors?
Epidemiol Infect. 2021;149:e23.
PubMed Abstract available

LI W, Gong J, Zhou J, Zhang L, et al
An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
Epidemiol Infect. 2021;149:e2.
PubMed Abstract available

GE Y, Sun S, Shen Y
Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report.
Epidemiol Infect. 2021;149:e14.
PubMed Abstract available

SALMON RL, Monaghan SP
Who is dying from COVID-19 in the United Kingdom? A review of cremation authorisations from a single South Wales' crematorium.
Epidemiol Infect. 2021;149:e13.
PubMed Abstract available

SHARIF N, Dey SK
Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh.
Epidemiol Infect. 2021;149:e16.
PubMed Abstract available

LIU Y, Haussinger L, Steinacker JM, Dinse-Lambracht A, et al
Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution.
Epidemiol Infect. 2021;149:e19.
PubMed Abstract available

ILESANMI OS, Afolabi AA, Akande A, Raji T, et al
Infection prevention and control during COVID-19 pandemic: realities from health care workers in a north central state in Nigeria.
Epidemiol Infect. 2021;149:e15.
PubMed Abstract available

WEI ZY, Qiao R, Chen J, Huang J, et al
The influence of pre-existing hypertension on coronavirus disease 2019 patients.
Epidemiol Infect. 2021;149:e4.
PubMed Abstract available

LIANG C, Shen L
An analysis of coronavirus disease 2019 with spline regression at province level during first-level response to major public health emergency out of Hubei, China.
Epidemiol Infect. 2021;149:e10.
PubMed Abstract available

CHOW WK, Chow CL
A discussion on implementing pooling detection tests of novel coronavirus (SARS-CoV-2) for a large population.
Epidemiol Infect. 2021;149:e17.
PubMed Abstract available

DENG L, Zhang J, Wang M, Chen L, et al
Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis.
Epidemiol Infect. 2021;149:e144.
PubMed Abstract available

December 2020

WEI C, Lee CC, Hsu TC, Hsu WT, et al
Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.
Epidemiol Infect. 2020;149:e1.
PubMed Abstract available

FERNANDEZ-SALINAS J, Aragon-Caqueo D, Valdes G, Laroze D, et al
Modelling pool testing for SARS-CoV-2: addressing heterogeneity in populations.
Epidemiol Infect. 2020;149:e9.
PubMed Abstract available

YANG J, Ma Z, Lei Y
A meta-analysis of the association between obesity and COVID-19.
Epidemiol Infect. 2020;149:e11.
PubMed Abstract available

ARINO J, Bajeux N, Portet S, Watmough J, et al
Quarantine and the risk of COVID-19 importation.
Epidemiol Infect. 2020;148:e298.
PubMed Abstract available

YUNG CF, Saffari E, Liew C
Time to Rt < 1 for COVID-19 public health lockdown measures.
Epidemiol Infect. 2020;148:e301.
PubMed Abstract available

YOUNG BE, Mak TM, Ang LW, Sadarangani S, et al
Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness.
Epidemiol Infect. 2020 Dec 2:1-29. doi: 10.1017/S0950268820002952.
PubMed

DE ALMEIDA GB, Pronunciate M, Grotto RMT, Azevedo Pugliesi E, et al
Two hundred days of COVID-19 in Sao Paulo State, Brazil.
Epidemiol Infect. 2020;148:e295.
PubMed Abstract available

ANDRADE LA, Gomes DS, Lima SVMA, Duque AM, et al
COVID-19 mortality in an area of northeast Brazil: epidemiological characteristics and prospective spatiotemporal modelling.
Epidemiol Infect. 2020;148:e288.
PubMed Abstract available

MO P, Deng L, Liu X, Gao S, et al
Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study.
Epidemiol Infect. 2020;148:e293.
PubMed Abstract available

November 2020

MANCILLA-GALINDO J, Vera-Zertuche JM, Navarro-Cruz AR, Segura-Badilla O, et al
Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19.
Epidemiol Infect. 2020;148:e286.
PubMed Abstract available

THOMPSON JV, Meghani NJ, Powell BM, Newell I, et al
Patient characteristics and predictors of mortality in 470 adults admitted to a district general hospital in England with Covid-19.
Epidemiol Infect. 2020;148:e285.
PubMed Abstract available

CAO Y, Wang Y, Das A, Pan CQ, et al
Transmission dynamics of COVID-19 among index case family clusters in Beijing, China.
Epidemiol Infect. 2020;149:e74.
PubMed Abstract available

HABONIMANA D, Ouedraogo L, Ndirahisha E, Misago N, et al
Understanding the influence of the COVID-19 pandemic on hospital-based mortality in Burundi: a cross-sectional study comparing two time periods.
Epidemiol Infect. 2020;148:e280.
PubMed Abstract available

SANTAMARIA L, Hortal J
Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain.
Epidemiol Infect. 2020;148:e282.
PubMed Abstract available

SUNG J, Choudry N, Bachour R
Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.
Epidemiol Infect. 2020;148:e273.
PubMed Abstract available

SULYOK M, Walker M
Community movement and COVID-19: a global study using Google's Community Mobility Reports.
Epidemiol Infect. 2020;148:e284.
PubMed Abstract available

SHAKIBA M, Nazemipour M, Heidarzadeh A, Mansournia MA, et al
Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey.
Epidemiol Infect. 2020;148:e300.
PubMed Abstract available

KAZANCIOGLU S, Bastug A, Ozbay BO, Kemirtlek N, et al
The Role of Hematological Parameters in Patients with Coronavirus Disease 2019 and Influenza Virus Infection.
Epidemiol Infect. 2020 Nov 5:1-16. doi: 10.1017/S095026882000271.
PubMed

GREBE G, Velez JA, Tiutiunnyk A, Aragon-Caqueo D, et al
Dynamic quarantine: a comparative analysis of the Chilean public health response to COVID-19.
Epidemiol Infect. 2020;148:e270.
PubMed Abstract available

GURSAKAL N, Batmaz B, Aktuna G
Drawing transmission graphs for COVID-19 in the perspective of network science.
Epidemiol Infect. 2020;148:e269.
PubMed Abstract available

October 2020

ISLAM MZ, Riaz BK, Islam ANMS, Khanam F, et al
Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
Epidemiol Infect. 2020;148:e263.
PubMed Abstract available

RIVERA R, Rosenbaum JE, Quispe W
Excess mortality in the United States during the first three months of the COVID-19 pandemic.
Epidemiol Infect. 2020;148:e264.
PubMed Abstract available

MAJUMDAR P, Niyogi S
ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
Epidemiol Infect. 2020;148:e262.
PubMed Abstract available

MEIKSIN A
Dynamics of COVID-19 transmission including indirect transmission mechanisms: a mathematical analysis.
Epidemiol Infect. 2020;148:e257.
PubMed Abstract available

ZHANG SX, Graf-Vlachy L, Looi KH, Su R, et al
Social media use as a predictor of handwashing during a pandemic: evidence from COVID-19 in Malaysia.
Epidemiol Infect. 2020;148:e261.
PubMed Abstract available

ZENG L, Wang S, Cai J, Sun S, et al
Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis.
Epidemiol Infect. 2020;148:e266.
PubMed Abstract available

DE SALAZAR PM, Gomez-Barroso D, Pampaka D, Gil JM, et al
Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain.
Epidemiol Infect. 2020;148:e268.
PubMed Abstract available

LI X, Marmar T, Xu Q, Tu J, et al
Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case-control study.
Epidemiol Infect. 2020;148:e255.
PubMed Abstract available

BRANDL M, Selb R, Seidl-Pillmeier S, Marosevic D, et al
Mass gathering events and undetected transmission of SARS-CoV-2 in vulnerable populations leading to an outbreak with high case fatality ratio in the district of Tirschenreuth, Germany.
Epidemiol Infect. 2020;148:e252.
PubMed Abstract available

TEIXEIRA R, Doetsch J
The multifaceted role of mobile technologies as a strategy to combat COVID-19 pandemic.
Epidemiol Infect. 2020;148:e244.
PubMed Abstract available

TAKAYA S, Tsuzuki S, Hayakawa K, Kawashima A, et al
Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.
Epidemiol Infect. 2020;148:e250.
PubMed Abstract available

GOODALL JW, Reed TAN, Ardissino M, Bassett P, et al
Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.
Epidemiol Infect. 2020;148:e251.
PubMed Abstract available

KHAN ZS, Van Bussel F, Hussain F
A predictive model for Covid-19 spread - with application to eight US states and how to end the pandemic.
Epidemiol Infect. 2020;148:e249.
PubMed Abstract available

SIFF EJ, Aghagoli G, Gallo Marin B, Tobin-Tyler E, et al
SARS-CoV-2 transmission: a sociological review.
Epidemiol Infect. 2020;148:e242.
PubMed Abstract available

WANG Y, Xu C, Yao S, Zhao Y, et al
Forecasting the epidemiological trends of COVID-19 prevalence and mortality using the advanced alpha-Sutte Indicator.
Epidemiol Infect. 2020;148:e236.
PubMed Abstract available

GUO J, Zhou B, Zhu M, Yuan Y, et al
CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
Epidemiol Infect. 2020;148:e241.
PubMed Abstract available

September 2020

SHI P, Ren G, Yang J, Li Z, et al
Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective study.
Epidemiol Infect. 2020;148:e238.
PubMed Abstract available

SINGH D, Joshi K, Samuel A, Patra J, et al
Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations.
Epidemiol Infect. 2020;148:e229.
PubMed Abstract available

LOPEZ-ABENTE J, Valor-Suarez C, Lopez-Abente G
Massive application of the SARS-CoV-2 diagnostic test: simulation of its effect on the evolution of the epidemic in Spain.
Epidemiol Infect. 2020;148:e233.
PubMed Abstract available

FERNANDES DE, Ferreira PRA, Mastroianni Kirsztajn G
Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?
Epidemiol Infect. 2020;148:e231.
PubMed Abstract available

GUBENSEK J, Vajdic Trampuz B, Persic V, Gregorcic S, et al
The possibility of SARS-CoV-2 transmission in a haemodialysis unit - report from a large in-hospital centre.
Epidemiol Infect. 2020;148:e226.
PubMed Abstract available

SARASWATHI S, Mukhopadhyay A, Shah H, Ranganath TS, et al
Social network analysis of COVID-19 transmission in Karnataka, India.
Epidemiol Infect. 2020;148:e230.
PubMed Abstract available

ZONGO P, Zorom M, Mophou G, Dorville R, et al
A model of COVID-19 transmission to understand the effectiveness of the containment measures: application to data from France.
Epidemiol Infect. 2020;148:e221.
PubMed Abstract available

CHEEMA S, Ameduri M, Abraham A, Doraiswamy S, et al
The COVID-19 pandemic: the public health reality.
Epidemiol Infect. 2020;148:e223.
PubMed Abstract available

CHEN M, Wei X, Wang Z
Protecting healthcare workers from SARS-CoV-2 and other infections.
Epidemiol Infect. 2020;148:e217.
PubMed Abstract available

AHMAD I, Muhammad Asad S
Predictions of coronavirus COVID-19 distinct cases in Pakistan through an artificial neural network.
Epidemiol Infect. 2020;148:e222.
PubMed Abstract available

CHEN LZ, Lin ZH, Chen J, Liu SS, et al
Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19?
Epidemiol Infect. 2020;148:e218.
PubMed Abstract available

SONG W, Sawafta FJ, Ebrahem BM, Jebril MA, et al
Public attitude towards quarantine during the COVID-19 outbreak.
Epidemiol Infect. 2020;148:e220.
PubMed Abstract available

DUAN P, Deng ZQ, Pan ZY, Wang YP, et al
Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.
Epidemiol Infect. 2020;148:e214.
PubMed Abstract available

HAW NJL, Uy J, Sy KTL, Abrigo MRM, et al
Epidemiological profile and transmission dynamics of COVID-19 in the Philippines.
Epidemiol Infect. 2020;148:e204.
PubMed Abstract available

TINTO B, Salinas S, Dicko A, Kagone TS, et al
Spreading of SARS-CoV-2 in West Africa and assessment of risk factors.
Epidemiol Infect. 2020;148:e213.
PubMed Abstract available

ELIMIAN KO, Ochu CL, Ilori E, Oladejo J, et al
Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February-6 June 2020.
Epidemiol Infect. 2020;148:e208.
PubMed Abstract available

BISWAS RK, Afiaz A, Huq S
Underreporting COVID-19: the curious case of the Indian subcontinent.
Epidemiol Infect. 2020;148:e207.
PubMed Abstract available

WANG X, Li X, Shang Y, Wang J, et al
Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
Epidemiol Infect. 2020;148:e211.
PubMed Abstract available

HAIDER N, Yavlinsky A, Chang YM, Hasan MN, et al
The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.
Epidemiol Infect. 2020;148:e210.
PubMed Abstract available

GAYAWAN E, Awe OO, Oseni BM, Uzochukwu IC, et al
The spatio-temporal epidemic dynamics of COVID-19 outbreak in Africa.
Epidemiol Infect. 2020;148:e212.
PubMed Abstract available

August 2020

LAI R, Chen E, Gao W, Cheng C, et al
Sentinel surveillance strategies for early detection of coronavirus disease in fever clinics: experience from China.
Epidemiol Infect. 2020;148:e205.
PubMed Abstract available

LANARI M, Anderson EJ, Sheridan-Pereira M, Carbonell-Estrany X, et al
Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies.
Epidemiol Infect. 2020;148:e170.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.